Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Madsen

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
BMC Cancer|October 9, 2024
The prognostic role of circulating tumour DNA detected prior to clinical diagnosis of colorectal cancer in the HUNT studySiv Stakset Brenne, Poul Henning Madsen, Inge Søkilde Pedersen, et al.
British Journal of Cancer|July 12, 2023
Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT studySiv S Brenne, Poul Henning Madsen, Inge Søkilde Pedersen, et al.
Journal of Breath Research|May 9, 2025
Exhaled breath protein composition in patients hospitalised during the first wave of COVID-19Inger Lise Gade, Jacob Bodilsen, Theis Mariager, et al.
Clinical Epigenetics|November 29, 2016
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinomaStine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, et al.
Oncotarget|February 23, 2018
The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancerSimon Ladefoged Rasmussen, Henrik Bygum Krarup, Kåre Gotschalck Sunesen, et al.
Cancers|November 27, 2021
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic AdenocarcinomaBenjamin Emil Stubbe, Stine Dam Henriksen, Poul Henning Madsen, et al.
BMJ Open|June 1, 2012
Focused sonographic examination of the heart, lungs and deep veins in an unselected population of acute admitted patients with respiratory symptoms: a protocol for a prospective, blinded, randomised controlled trialChristian Borbjerg Laursen, Erik Sloth, Annmarie Touborg Lassen, et al.
The Lancet. Respiratory Medicine|July 8, 2014
Point-of-care ultrasonography in patients admitted with respiratory symptoms: a single-blind, randomised controlled trialChristian B Laursen, Erik Sloth, Annmarie Touborg Lassen, et al.
Plos One|July 13, 2017
Hypermethylated DNA, a circulating biomarker for colorectal cancer detectionSimon Ladefoged Rasmussen, Henrik Bygum Krarup, Kåre Gotschalck Sunesen, et al.
Scandinavian Journal of Gastroenterology|June 8, 2012
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis CPeer Brehm Christensen, Henrik Bygum Krarup, Alex Lund Laursen, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
BMC Cancer|October 9, 2024
The prognostic role of circulating tumour DNA detected prior to clinical diagnosis of colorectal cancer in the HUNT studySiv Stakset Brenne, Poul Henning Madsen, Inge Søkilde Pedersen, et al.
British Journal of Cancer|July 12, 2023
Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT studySiv S Brenne, Poul Henning Madsen, Inge Søkilde Pedersen, et al.
Journal of Breath Research|May 9, 2025
Exhaled breath protein composition in patients hospitalised during the first wave of COVID-19Inger Lise Gade, Jacob Bodilsen, Theis Mariager, et al.
Clinical Epigenetics|November 29, 2016
Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinomaStine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, et al.
Oncotarget|February 23, 2018
The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancerSimon Ladefoged Rasmussen, Henrik Bygum Krarup, Kåre Gotschalck Sunesen, et al.
Cancers|November 27, 2021
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic AdenocarcinomaBenjamin Emil Stubbe, Stine Dam Henriksen, Poul Henning Madsen, et al.
BMJ Open|June 1, 2012
Focused sonographic examination of the heart, lungs and deep veins in an unselected population of acute admitted patients with respiratory symptoms: a protocol for a prospective, blinded, randomised controlled trialChristian Borbjerg Laursen, Erik Sloth, Annmarie Touborg Lassen, et al.
The Lancet. Respiratory Medicine|July 8, 2014
Point-of-care ultrasonography in patients admitted with respiratory symptoms: a single-blind, randomised controlled trialChristian B Laursen, Erik Sloth, Annmarie Touborg Lassen, et al.
Plos One|July 13, 2017
Hypermethylated DNA, a circulating biomarker for colorectal cancer detectionSimon Ladefoged Rasmussen, Henrik Bygum Krarup, Kåre Gotschalck Sunesen, et al.
Scandinavian Journal of Gastroenterology|June 8, 2012
Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis CPeer Brehm Christensen, Henrik Bygum Krarup, Alex Lund Laursen, et al.
Pageof 5